Convergence is an invitation-only gathering of one hundred pharmaceutical executives, biotech entrepreneurs, medical device innovators, academic researchers, and life sciences investors from the Northeast and beyond. Request an invitation.

Companies that were represented at Convergence 2009 included:

Achaogen GlaxoSmithKline
Acucela Halloran Consulting Group
Aisling Capital Harvard Pilgrim Health Care 
Aleva Neurotherapeutics, S.A. Innov. Fund, Partners Healthcare
Alexandria Real Estate Equities International AIDS Vaccine Initiative
Alnylam Pharmaceuticals InterWest Partners
Arsenal Medical Intra-Cellular Therapies, Inc. 
ArtisanPharma, Inc. J. Robert Scott
Astrazeneca Krasner Health Strategies
Atlantic Healthcare Ltd. MacDougall Biomed. Comm.
Atlas Venture Mass Eye and Ear Infirmary
Aura Biosciences Mass High Tech
Avecia Biotechnology MDinteractive
AVEO Pharmaceuticals, Inc. Merck & Co. Inc.
BayCross Capital Group MicroCHIPS, Inc.
Beth Israel Deaconess Med Ctr. MPM Capital 
BioCentury Neurotech
Biogen Idec NKT Therapeutics
BioScale, Inc. Novartis Inst. for Biomedical Research
Biotechnology Industry Org. Novartis Venture Funds
BioTrove Osher Research Center
Blue Cross Blue Shield of MA Oxford Bioscience Partners
Boston Globe OXO Capital LLC
Boston Scientific Corp. Partners HealthCare
Broad Institute Polaris Venture Partners
CBT Advisors Posky LLC
Celerant Consulting PTC Therapeutics
Certus Biomedical  Pure Communications Inc.
City of Providence PureTech Ventures
CHL Medical Partners Quaker BioVentures
Co-Bio Consulting, LLC Red Sky Partners
CombinatoRx RiboNovix, Inc.
Covington Associates RMG Associates, LLC
Cyberkinetics Science Club for Girls
Cytel Inc. Seaside Therapeutics
EGS Healthcare Capital Partners Silicon Valley Bank
ElectroSonics Medical Inc. Skyline Ventures
Enanta Pharmaceutical, Inc. Slater Technology Fund
ENTRA Pharmaceuticals Stromedix
Envoi Ventures Strategic Science & Technologies LLC
Eutropics Pharmaceuticals Surface Logix
Fidelity Biosciences Synta Pharmaceuticals
FoldRx Pharmaceuticals, Inc. Taligen Therapeutics, Inc.
Foley and Lardner LLP TheraGenetics, Ltd.
Forma Therapeutics TLV Partners
Gene Network Sciences Transport Pharmaceuticals
Genzyme Corporation TVM Capital
The GI Company Inc. Waltham Technologies
GlaxoSmithKline Wyeth
GPC-RX